Fine Chemicals Market – By Type , By Application and By Geography - Global Opportunity Analysis & Industry Forecast, 2023-2030

Report Code: CMR 0411 Report Format: PDF + Excel

Fine Chemicals Market Overview

Fine Chemicals market size is forecast to reach US$274 billion by 2030, after growing at a CAGR of 5.7% during 2024-2030. Fine chemicals can be defined as pure, complex as well as single chemicals that are produced in multipurpose plants by biotechnological process or batch production methods. Moreover, these are generally manufactured at lower quantities and are sold at higher prices. These chemicals are used in special applications as a starting material for the manufacture of biocides, generic drugs, paints and specialty chemicals. One of the major factors driving the growth of fine chemicals market is growing demand for fine chemicals in pharmaceutical sector. Also, the increasing demand for agrochemicals and rise in construction activities will boost the fine chemical market.

A significant trend in the Fine Chemicals Market is the use of green fine chemicals. These are produced using environmentally friendly processes that minimize the use of hazardous substances, reduce energy consumption and generate less waste. Due to the growing sustainability demand, the chemical industry also aims to employ sustainable manufacturing processes and produce chemicals that are eco-friendly. In November 2023, Lotte Fine Chemical Co. announced an investment of $99 million in an aim to become the world’s largest food and pharmaceutical materials producer and bump up its green materials sales by six times by 2030. Another trend in the market is supply chain diversification. The increasing geopolitical tensions and supply chain disruptions particularly related to China are driving a strong trend towards diversifying sourcing options for fine chemicals.

Market Snapshot: 


Fine Chemicals  Report Coverage

The report "Fine Chemicals Market Report – Forecast (2024-2030)" by IndustryARC covers an in-depth analysis of the following segments of the Fine Chemicals Market.

Attribute Segment

By Type

By Application
  • Pharmaceuticals
  • Cosmetics
  • Agriculture
  • Electronics
  • Food and Beverage
  • Petrochemicals
  • Plastics
  • Metal and Mining
  • Others

By Geography

  • North America (U.S, Canada and Mexico)
  • Europe (Germany, France, UK, Italy, Spain, Netherlands, Russia and Rest of Europe),
  • Asia-Pacific (China, Japan, South Korea, India, Australia, Malaysia, Indonesia and Rest of Asia-Pacific),
  • South America (Brazil, Argentina, Chile, Colombia and Rest of South America)
  • Rest of the World (Middle East and Africa).

COVID-19 / Ukraine Crisis - Impact Analysis:  

  • The Fine Chemicals industry witnessed the demand for automation during the COVID 19 pandemic which arose due to the need to minimize human interaction and safety. Additionally, the change in consumer behavior from minimally processed foods to packaged and processed necessitated machinery upgrades to accommodate increased production volumes and necessitated manufacturers to rethink their machinery requirements.
  • The Russia-Ukraine war drastically affected the supply of critical agricultural exports mainly grains and sunflower oil, which are essential in the food processing industry. Sanctions and severed trade routes raised raw material costs, leading to machinery manufacturers to concentrate on energy efficient machinery and alternative modes of resource use. 

Key Takeaways

Active Pharmaceutical Ingredients are the Largest Segment

Active pharmaceutical ingredients (APIs) are the active components in a pharmaceutical drug (pill, capsule, cream, injectable etc.) that produce the required effect on the body to treat a condition. Despite high manufacturing costs, stringent regulatory policies, and policies in controlling drug prices in many countries, attractive opportunities have emerged in the API market due to growing incidence of chronic or non-communicable diseases. In June 2024, Pfizer commissioned its expanded, highly automated active pharmaceutical ingredient (API) manufacturing facility at the Tuas Biomedical Park in Singapore. The $744 million facility covers 429,000 square feet and will produce antibiotics and small molecules for Pfizer’s oncology, pain and antibiotic medicines. APIs find application in high quality drugs that treat diseases pertaining to oncology, cardiology, CNS and neurology, orthopedic, pulmonology, gastroenterology, nephrology, ophthalmology and endocrinology.

Pharmaceuticals are the Largest Segment

Pharmaceutical fine chemicals can be defined as the set of products or active pharmaceutical ingredients as well as services such as process development and optimization associated with the access by pharmaceutical companies to the API throughout the product life cycle, as per Contact Pharma. The key driver of the pharmaceutical market growth is the budding API manufacturing in developing countries. India and China produce APIs and drug intermediates for regulated markets. As the pharmaceutical industry is highly competitive, the ability to offer a low price is crucial. Generic drug manufacturers outsource bulk drug manufacturing activities to API manufacturers in developing countries, who deliver the APIs at a low cost. In 2023, India exported Active Pharmaceutical Ingredients (APIs) worth approximately $5.5 billion, as per data from the Directorate General of Commercial Intelligence and Statistics (DGCI&S).

North America Leads the Market

North America occupies the largest market share in the Fine Chemicals Market due to the demand from pharmaceutical and agrochemical industries which are the largest consumers of these chemicals. In May 2024, theU. S. Department of Agriculture (USDA) Secretary announced that USDA is investing in domestic fertilizer projects. As per the announcement, the Department is awarding $83 million in 12 states for projects through the Fertilizer Production Expansion Program (FPEP). This program provides grants to independent business owners to help them modernize equipment, adopt new technologies, build production plants and more. These investments will boost domestic fertilizer production, strengthen competition and lower costs for U.S. farmers. Additionally, the region advanced manufacturing capabilities, robust R&D infrastructure and several players that prioritize innovation and quality. Furthermore, the strict regulatory standards such as those enforced by the FDA and EPA drive the demand for high-purity fine chemicals in drug development and crop protection applications. The presence of well-established supply chains and strategic partnerships between chemical manufacturers and end-use industries further strengthens the region’s dominance. Moreover, North America benefits from substantial investments in biopharmaceuticals, specialty chemicals and sustainable practices. 

Rising Demand for Pharmaceuticals Drives the Market

The growth scope for fine chemicals for active pharmaceutical ingredients is high compared to other types due to its wide range of applicability in drugs for the medical and pharmaceuticals sector to treat a rising number of chronic diseases. The demand for fine chemicals such as polypeptide, erythropoietin and others are growing due to the rising utilization of pharmaceuticals and biopharmaceuticals. In addition, the advancements in therapeutic drugs and medical devices and others are fueling its growth. In May 2024, Eli Lilly and Company announced a $5.3 billion investment in its manufacturing site in Lebanon, Indiana, US which increases the firm’s total investment to $9 billion. This expansion will expand manufacturing capacity of active pharmaceutical ingredients (APIs) for Zepbound (tirzepatide) injection and Mounjaro (tirzepatide) injection. Thus, with the massive utilization of these fine chemicals in pharmaceuticals for drugs and medications, the demand for fine chemicals is projected to grow rapidly during the forecast period.

Stringent Safety and Environmental Concerns to Hamper the Market

Fine chemicals have various negative impacts on the environment which restrains the growth of the fine chemicals market. Various strict regulations and strict rules regarding the negative effects of fine chemicals on the environment can act as a major constraint.  These include regulations and initiatives taken by industrial associations in order to set standards for the management of an organization’s environmental impacts, product certification and issuance of licenses to decrease the harmful impact on the environment and adoption of clean technologies and improvement in management practices under CREP (Corporate Responsibility for Environmental Protection) Programs formulated by the Central Pollution Control Board. 


Fine Chemicals Market

For more details on this report - Request for Sample

Fine Chemicals Industry Outlook

Technology launches, acquisitions, and R&D activities are key strategies adopted by players in the Fine Chemicals Market. Global Fine Chemicals top 10 companies include:

  1. BASF SE
  2. Sumitomo Chemical Company
  3. LANXESS
  4. Lonza Group
  5. Lotte Fine Chemical Co., Ltd
  6. Novonesis Group
  7. Arkema
  8. Solvay S.A
  9. Evonik Industries
  10. Boehringer-Ingelheim

Scope of the Report:

Report Metric Details

Base Year Considered

2023

Forecast Period

2024–2030

CAGR

5.7%

Market Size in 2030

$274 Billion

Segments Covered

By Type, By Application and By Geography

Geographies Covered

North America (U.S, Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Netherlands, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia, Malaysia, Indonesia and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America) and Rest of the World (Middle East and Africa)

Key Market Players
  1. BASF SE
  2. Sumitomo Chemical Company
  3. LANXESS
  4. Lonza
  5. Lotte Fine Chemical Co., Ltd
  6. Novonesis Group
  7. Arkema
  8. Solvay S.A
  9. Evonik Industries
  10. Boehringer-Ingelheim

 

For more Chemicals and Materials Market reports, please click here

  1.    Fine Chemicals Market- Market Overview
      1.1.    Definitions and Scope
  2.    Fine Chemicals Market - Executive Summary
      2.1.    Key Trends by Type
      2.2.    Key Trends by Application
      2.3.    Key Trends by Geography
  3.    Fine Chemicals Market – Comparative analysis
      3.1.    Market Share Analysis- Major Companies
      3.2.    Product Benchmarking- Major Companies
      3.3.    Top 5 Financials Analysis
      3.4.    Patent Analysis- Major Companies
      3.5.    Pricing Analysis (ASPs will be provided)
  4.    Fine Chemicals Market - Startup Companies Scenario 
      4.1.    Major startup company analysis:
            4.1.1.    Investment
            4.1.2.    Revenue
            4.1.3.    Product portfolio
            4.1.4.    Venture Capital and Funding Scenario
  5.    Fine Chemicals Market – Industry Market Entry Scenario Premium 
      5.1.    Regulatory Framework Overview
      5.2.    New Business and Ease of Doing Business Index
      5.3.    Successful Venture Profiles
      5.4.    Customer Analysis – Major companies
  6.    Fine Chemicals Market - Market Forces
      6.1.    Market Drivers
      6.2.    Market Constraints
      6.3.    Porters Five Force Model
            6.3.1.    Bargaining Power of Suppliers
            6.3.2.    Bargaining Powers of Buyers
            6.3.3.    Threat of New Entrants
            6.3.4.    Competitive Rivalry
            6.3.5.    Threat of Substitutes
  7.    Fine Chemicals Market – Strategic Analysis
      7.1.    Value/Supply Chain Analysis
      7.2.    Opportunity Analysis
      7.3.    Product/Market Life Cycle
      7.4.    Distributor Analysis – Major Companies
  8.    Fine Chemicals Market – By Type (Market Size -US$ Million/Billion)
      8.1 Active Pharmaceutical Ingredients 
                8.1.1 Pills 
                              8.1.1.1 Synthetic Active Pharmaceutical Ingredients 
                              8.1.1.2 Biological Active Pharmaceutical Ingredients 
                8.1.2 Capsules 
                              8.1.2.1 Synthetic Active Pharmaceutical Ingredients 
                              8.1.2.2 Biological Active Pharmaceutical Ingredients 
      8.2 Agrochemicals 
                8.2.1 Pesticides 
                8.2.2 Fungicides 
                8.2.3 Biocides 
                8.2.4 Herbicides 
      8.3 Specialty Chemicals 
                8.3.1 Adhesives 
                8.3.2 Additives 
                8.3.3 Construction Chemicals 
                8.3.4 Oilfield Chemicals 
                8.3.5 Specialty Polymers 
                8.3.6 Specialty Pigments and Dyes 
                8.3.7 Others
  9.    Fine Chemicals Market – By Application (Market Size -US$ Million/Billion)
      9.1 Pharmaceuticals 
      9.2 Cosmetics 
                 9.2.1 Skin Care 
                 9.2.2 Hair Care 
                 9.2.3 Fragrances 
                 9.2.4 Others 
      9.3 Agriculture 
      9.4 Electronics 
      9.5 Food and Beverage 
                9.5.1 Preservatives 
                9.5.2 Additives 
                9.5.3 Others 
      9.6 Petrochemicals 
      9.7 Plastics 
      9.8 Metal and Mining 
      9.9 Others
  10.    Fine Chemicals Market - By Geography (Market Size -US$ Million/Billion)
      10.1.    North America
            10.1.1.    USA
            10.1.2.    Canada
            10.1.3.    Mexico
      10.2.    Europe
            10.2.1.    UK
            10.2.2.    Germany
            10.2.3.    France
            10.2.4.    Italy
            10.2.5.    Netherlands
            10.2.6.    Spain
            10.2.7.    Russia
            10.2.8.    Rest of Europe
      10.3.    Asia-Pacific
            10.3.1.    China
            10.3.2.    Japan
            10.3.3.    India
            10.3.4.    South Korea
            10.3.5.    Australia 
            10.3.6.    Indonesia
            10.3.7.    Malaysia
            10.3.8.    Rest of APAC
      10.4.    South America
            10.4.1.    Brazil
            10.4.2.    Argentina
            10.4.3.    Colombia
            10.4.4.    Chile
            10.4.5.    Rest of South America
      10.5.    Rest of the World
            10.5.1.    Middle East
            10.5.2.    Africa
  11.    Fine Chemicals Market – Entropy
      11.1.    New Product Launches
      11.2.    M&As, Collaborations, JVs and Partnerships
  12.    Fine Chemicals Market – Industry/Segment Competition Landscape 
      12.1.    Market Share Analysis
            12.1.1.    Market Share by Country - Major Companies
            12.1.2.    Market Share by Region - Major Companies
            12.1.3.    Market Share by Type of Application - Major Companies
            12.1.4.    Market Share by Type of Product/Product Category - Major Companies
      12.2.    Competition Matrix
      12.3.    Best Practices for Companies
  13.    Fine Chemicals Market – Key Company List by Country Premium 
  14.    Fine Chemicals Market Company Analysis - Business Overview, Product Portfolio, Financials, and Developments
      14.1.    BASF SE
      14.2.    Sumitomo Chemical Company
      14.3.    LANXESS
      14.4.    Lonza 
      14.5.    Lotte Fine Chemical Co., Ltd
      14.6.    Novonesis Group
      14.7.    Arkema
      14.8.    Solvay S.A
      14.9.    Evonik Industries
      14.10.    Boehringer-Ingelheim    
     
  “Financials to the Private Companies would be provided on best-effort basis.”
  Connect with our experts to get customized reports that best suit your requirements. Our reports include global-level data, niche markets and competitive landscape.
   
LIST OF TABLES:
 
Table 1: Fine Chemicals Market Revenue, By End-User, 2013-2021 ($Billion)
Table 2: Colors Certified for Use In Foods. From CFR (2004d)
Table 3: Europe Fine Chemicals Market Revenue, By End-User, 2013 - 2021 ($ Mn)
Table 4: APAC: Fine Chemicals Market Revenue, By End-User, 2013 - 2021 ($Million)
Table 5: North America: Fine Chemicals Market Revenue, By End-User, 2013 - 2021 ($Million)
Table 6: RoW: Fine Chemicals Market Revenue, By End-User, 2013 - 2021 ($Million)
 
 
LIST OF FIGURES:
 
Figure 1: Fine Chemicals Market Revenue, By Years, 2013-2021 ($Billion)
Figure 2: Fine Chemicals Market Revenue, By Region, 2016 and 2021 (%)
Figure 3: Fine Chemicals Market Share Analysis, By Company 2016 (%)
Figure 4: Fine Chemicals Market: Earnings Per Share, By Company, 2014-2016, ($ per Share)
Figure 5: Fine Chemicals Published Patents, 2012-2023*
Figure 6: Fine Chemicals Published Patents Share, By Countries, 2012-2023* (%)
Figure 7: Varicose Veins Market –Porter’s Five Forces
Figure 8: Fine Chemicals Market, API Pricing Analysis, 2013-2021
Figure 9: Figure: Fine Chemicals Market Life Cycle, 2016.2021
Figure 10: Fine Chemicals Market Revenue Share, By End User, 2016 (%)
Figure 11: Fine Chemicals Market Revenue, By End User, 2016-2021 ($Million)
Figure 12: Indian Pharmaceutical Market Revenue, 2005-2020 ($Billion)
Figure 13: Pharmaceuticals: Fine Chemicals Market Revenue, 2013-2021 ($Million)
Figure 14: Global Pesticide Market share, 2016 (%)
Figure 15: Agrochemicals: Fine Chemicals Market Revenue, 2013-2021 ($Million)
Figure 16: World Frozen Foods Share, 2016 (%) 
Figure 17: Food and Feed: Fine Chemicals Market Revenue, 2013-2021 ($Million)
Figure 18: Production by Global Electronics and IT Industries share, 2015(%)
Figure 19: Consumer Electronics Products and Services Segmentation, 2015 (%) 
Figure 20: U.S. Consumer Electronics Shipments Revenues, 2005-2016, ($Billion)
Figure 21: Figure: Global Smart Phone Shipments, 2009-2019 (Million Units)
Figure 22: Electronics: Fine Chemicals Market Revenue, 2013-2021 ($Million)
Figure 23: Liquid Crystal: Fine Chemicals Market Revenue, 2013-2021 ($Million)
Figure 24: Functional Dye: Fine Chemicals Market Revenue, 2013-2021 ($Million)
Figure 25: Others: Fine Chemicals Market Revenue, 2013-2021 ($Million)
Figure 26: U.S. Bakery Products Sales Share by Category, 2016 (%)
Figure 27: World's Top Ten Paint Brands in 2016, Net Sales, ($ Billion)
Figure 28: Global Textile Exports, By Country, 2016 (%)
Figure 29: Pigments: Fine Chemicals Market Revenue, 2013-2021 ($Million)
Figure 30: Dyes: Fine Chemicals Market Revenue, 2013-2021 ($Million)
Figure 31: Global Hair Care Product Launches-2016
Figure 32: Global Personal Care Market Revenue, 2016 ($Million)
Figure 33: REVENUE OF COSMETIC INDUSTRY IN U.S., 2006-2016 ($Billion)
Figure 34: Fragrances and Flavors Revenue Share, 2015
Figure 35: Perfumes and Fragrances: Fine Chemicals Market Revenue, 2013-2021 ($Million)
Figure 36: Global Food Processing and Packaging Equipment Market Revenue, 2012-2020, ($Billion)
Figure 37: Global Automobile Sales, 2010 – 2014 (Units)
Figure 38: Polymer Additives: Fine Chemicals Market Revenue, 2013-2021 ($Million)
Figure 39: Others: Fine Chemicals Market Revenue, 2013-2021 ($Million)
Figure 40: Global Fine Chemicals Market Revenue, By Geography,2013 vs. 2021 ($ Mn) 
Figure 41: Europe: Pharmaceutical Market Overview, 2000 - 2015 ($ Million)
Figure 42: Europe Fine Chemicals Market Revenue, 2013 - 2021 ($ Mn)
Figure 43: Germany: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 44: Germany: GDP – Composition of 2015, By Sector of Origin
Figure 45: Germany: Export and Import Value, 2012-2015 ($Billion)
Figure 46: Germany Pharmaceuticals Industry Overview, 2014 ($ Million)
Figure 47: Germany Fine Chemicals Market Revenue, 2013 - 2021 ($Million)
Figure 48: France: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 49: France: GDP – Composition of 2015, By Sector of Origin
Figure 50: France: Export and Import Value, 2012-2015 ($Billion)
Figure 51: France: Pharmaceutical Industry Overview, 2014 ($ Million)
Figure 52: France: Fine Chemicals Market Revenue, 2013 - 2021 ($Million)
Figure 53: France: Chemicals Industry Market Share, 2014 (%)
Figure 54: Italy: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 55: Italy: GDP – Composition of 2015, By Sector of Origin
Figure 56: Italy: Export and Import Value, 2012-2015 ($Billion)
Figure 57: Italy: Pharmaceutical Industry Overview, 2014 ($ Million)
Figure 58: Italy: Fine Chemicals Market Revenue, 2013 - 2021 ($Million)
Figure 59: Italy: Chemicals Production by Sector Share, 2014 (%)
Figure 60: Spain: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 61: Spain: GDP – Composition of 2016, By Sector of Origin
Figure 62: Spain: Export and Import Value, 2012-2015 ($Billion)
Figure 63: Spain: Pharmaceutical Industry Overview, 2014 ($ Million)
Figure 64: Spain Fine Chemicals Market Revenue, 2013 - 2021 ($Million)
Figure 65: Russia: Pharmaceutical Industry Overview, 2014 ($ Million)
Figure 66: Russia: Fine Chemicals Market Revenue, 2013 - 2021 ($Million)
Figure 67: U.K.: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 68: U.K.: GDP – Composition of 2015, By Sector of Origin
Figure 69: U.K.: Export and Import Value, 2012-2015 ($Billion)
Figure 70: UK: Pharmaceutical Industry Overview, 2014 ($ Million)
Figure 71: U.K.: Fine Chemicals Market Revenue, 2013 - 2021 ($Million)
Figure 72: Switzerland: Pharmaceutical Industry Overview, 2014 ($ Million)
Figure 73: Switzerland.: Fine Chemicals Market Revenue, 2013 - 2021 ($Million)
Figure 74: Rest of Europe: Fine Chemicals Market Revenue, By Type, 2013 - 2021 ($Million)
Figure 75: APAC: Fine Chemicals Market Revenue, 2013 - 2021 ($Million)
Figure 76: China: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 77: China: GDP – Composition of 2015, By Sector of Origin
Figure 78: China: Export and Import Value, 2012-2015 ($Billion)
Figure 79: China: Healthcare Expenditure Per Capita, 2011 – 2014, (US $)
Figure 80: China Fine Chemicals Market Revenue, 2013 - 2021 ($Million)
Figure 81: India: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 82: India: GDP – Composition of 2015, By Sector of Origin
Figure 83: India: Export and Import Value, 2012-2015 ($Billion)
Figure 84: India: Healthcare Expenditure Per Capita, 2011 - 2014, (US $)
Figure 85: India: Fine Chemicals Market Revenue, 2013 - 2021 ($Million)
Figure 86: Japan: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 87: Japan: GDP – Composition of 2015, By Sector of Origin
Figure 88: Japan: Export and Import Value, 2012-2015 ($Billion)
Figure 89: Japan: Healthcare Expenditure Per Capita, 2011 – 2014, (US $)
Figure 90: Japan Fine Chemicals Market Revenue, 2013 - 2021 ($Million)
Figure 91: South Korea: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 92: South Korea: GDP – Composition of 2015, By Sector of Origin
Figure 93: South Korea: Export and Import Value, 2012-2015 ($Billion)
Figure 94: South Korea: Healthcare Expenditure Per Capita, 2011 – 2014, (US $)
Figure 95: South Korea: Fine Chemicals Market Revenue, 2013 - 2021 ($Million)
Figure 96: Rest of APAC Fine Chemicals Market Revenue, 2013 - 2021 ($Million)
Figure 97: North America: Fine Chemicals Market Revenue, 2013 - 2021 ($Million)
Figure 98: U.S.: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 99: U.S.: GDP – Composition of 2015, By Sector of Origin
Figure 100: U.S.: Export and Import Value, 2012-2015 ($Trillion)
Figure 101: US: Healthcare Expenditure Per Capita, 2011 – 2014, (US $)
Figure 102: U.S. Fine Chemicals Market Revenue, 2013 - 2021 ($Million)
Figure 103: Canada: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 104: Canada: GDP – Composition of 2015, By Sector of Origin
Figure 105: Canada: Export and Import Value, 2012-2015 ($Billion)
Figure 106: Canada: Healthcare Expenditure Per Capita, 2011 – 2014, (US $)
Figure 107: Canada Fine Chemicals Market Revenue, 2013 - 2021 ($Million)
Figure 108: Mexico: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 109: Mexico: GDP – Composition of 2015, By Sector of Origin
Figure 110: Mexico: Export and Import Value, 2012-2015 ($Billion)
Figure 111: Mexico: Healthcare Expenditure Per Capita, 2011 – 2014, (US $)
Figure 112: Mexico: Healthcare Expenditure Per Capita, 2011 – 2014, (US $)
Figure 113: Mexico Fine Chemicals Market Revenue, 2013 - 2021 ($Million)
Figure 114: Rest of the World Fine Chemicals Market Revenue, 2013 - 2021 ($B)
Figure 115: Argentina: Healthcare Expenditure Per Capita, 2011 – 2014, US $
Figure 116: Argentina: GDP and Population, 2012-2015 ($Billion, Million)
Figure 117: Argentina: GDP – Composition of 2015, By Sector of Origin
Figure 118: Argentina: Export and Import Value, 2012-2015 ($Billion)
Figure 119: Brazil: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 120: Brazil: GDP – Composition of 2015, By Sector of Origin
Figure 121: Brazil: Export and Import Value, 2012-2015 ($Billion)
Figure 122: Brazil: Healthcare Expenditure Per Capita, 2011 – 2014, US $
Figure 123: South America Fine Chemicals Market Revenue, 2013 - 2021 ($Million)
Figure 124: UAE: Healthcare Expenditure Per Capita, US $
Figure 125: Middle East Fine Chemicals Market Revenue, 2013 - 2021 ($Million)
Figure 126: South Africa: Healthcare Expenditure Per Capita, 2011 – 2014, (US $)
Figure 127: Africa Fine Chemicals Market Revenue, 2013 - 2021 ($Million)
Figure 128: Lonza Group, Net Sales Share, By Business Segment, 2016 (%)
Figure 129: Lonza Group, Net Sales Share, By Geography, 2016 (%)
Figure 130: Lanxess AG, Net Sales, By Years, 2013-2016 ($Billion)
Figure 131: Lanxess AG, Net Sales Share, By Business Segment, 2016 (%)
Figure 132: Lanxess AG, Net Sales Share, By Geography, 2016 (%)
Figure 133: Johnson Matthey, Net Sales, By Years, 2013-2016 ($Billion)
Figure 134: Johnson Matthey Net Sales Share, By Business Segment, 2016 (%)
Figure 135: Johnson Matthey, Net Sales Share, By Geography, 2016 (%)
Figure 136: Arkema Inc., Net Sales, By Years, 2013-2016 ($Billion)
Figure 137: Arkema Inc. Net Sales Share, By Business Segment, 2016 (%)
Figure 138: Arkema Inc., Net Sales Share, By Geography, 2016 (%)
Figure 139: Akzo Nobel N.V. Net revenue, By Years, 2013-2016 ($Billion)
Figure 140: Akzo Nobel N.V. Net Sales Share, By Business segments, 2016 (%)
Figure 141: Akzo Nobel N.V. Net Sales Share, By Geography, 2016 (%)
Figure 142: Evonik Industries AG, Net Sales, By Years, 2013-2016 ($Billion)
Figure 143: Evonik Industries AG, Net Sales Share, By Business Segment, 2016 (%)
Figure 144: Evonik Industries AG, Net Sales Share, By Geography, 2016 (%)
Figure 145: Borregaard Industries Ltd., Net Sales, By Years, 2013-2016 ($Million)
Figure 146: Borregaard Industries Ltd. Net Sales Share, By Business Segment, 2016 (%)
Figure 147: Borregaard Industries Ltd., Net Sales Share, By Geography, 2016 (%)
Figure 148: CNPC, Net Sales, By Years, 2013-2016 ($Billion)
Figure 149: Solvay SA, Net Sales, By Years, 2013-2016 ($Billion)
Figure 150: Solvay Net Sales Share, By Business Segment, 2016 (%)
Figure 151: Solvay SA, Net Sales Share, By Geography, 2016 (%)
Figure 152: BASF SE, Net Sales, By Years, 2014-2016 ($Billion)
Figure 153: BASF SE, Net Sales Share, By Business segments, 2016 (%)
Figure 154: BASF SE, Net Sales Share, By Geography, 2016 (%)
Figure 155: Royal DSM N.V., Net Sales, By Years, 2013-2016 ($Billion)
Figure 156: Royal DSM N.V., Net Sales Share, By Business Segment, 2016 (%)
Figure 157: Royal DSM N.V., Net Sales Share, By Geography, 2016 (%)
Figure 158: Toray Fine Chemicals Co. Ltd., Net Sales, By Years, 2013-2015 ($Million)
Figure 159: Albemarle Corporation, Net Sales, By Years, 2013-2016 ($Billion)
Figure 160: Albemarle Corporation, Net Sales Share, By Business Segment, 2016 (%)
Figure 161: Albemarle Corporation, Net Sales Share, By Geography, 2016 (%)

The Fine Chemicals Market is projected to grow at 5.7% CAGR during the forecast period 2024-2030.

The Fine Chemicals Market size is estimated to be $185.9 billion in 2023 and is projected to reach $274 billion by 2030

The leading players in the Fine Chemicals Market are BASF SE, Sumitomo Chemical Company, LANXESS, Lonza, Lotte Fine Chemical Co., Ltd and Others

Green chemicals and diversification of the supply chain are some of the major Fine Chemicals Market trends in the industry which will create growth opportunities for the market during the forecast period.

Growing demand for pharmaceuticals due to the rising incidences of diseases, rising need for agrochemicals and demand for specialty chemicals are the driving factors of the market.